Zhengxian Gu and colleagues at PTC Therapeutics, Inc. in the U.S. will investigate the mechanism of action used by a class of small molecules shown to specifically activate HIV. Understanding the pathways for reactivation of latent HIV could inform development of drug therapies to eliminate latent HIV reservoirs and effectively cure HIV.
Grant ID
OPP1045786
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False